Skip to main content
Allen Ho, MD, Otolaryngology (ENT), Los Angeles, CA, Cedars-Sinai Medical Center

AllenSzu-HaoHoMD

Otolaryngology (ENT) Los Angeles, CA

Head & Neck Oncologic Surgery

Professor of Surgery; Director, Head & Neck Cancer Program; Co-Director, Thyroid Cancer Program

Dr. Ho is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ho's full profile

Already have an account?

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Head and Neck Surgical Oncology, 2011 - 2014
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Otolaryngology - Head and Neck Surgery, 2006 - 2011
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityInternship, Surgery, 2006 - 2007
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 2006
  • National Cancer Institute
    National Cancer Institute2003 - 2004
  • Harvard University
    Harvard UniversityBA, Neurobiology, 1996 - 2000

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2007 - 2025
  • NY State Medical License
    NY State Medical License 2011 - 2015
  • American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
  • American Head and Neck SocietyHead and Neck Surgical Oncology

Awards, Honors, & Recognition

  • Top Doctors 2021
  • Super Doctors 2021
  • Castle Connolly Top Doctors 2021
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association of quantitative metastatic lymph node burden with survival in hypopharyngeal and laryngeal cancer  
    Ho AS, Kim S, Tighiouart M, Gudino C, Mita A, Scher KS, Laury A, Prasad R, Shiao SL, Ali N, Patio C, Mallen-St Clair J, Van Eyk JE, Zumsteg ZS, JAMA Oncology, 11/30/2017
  • Metastatic lymph node burden and survival in oral cavity cancer  
    Ho AS, Kim S, Tighiouart M, Gudino C, Mita A, Scher KS, Laury A, Prasad R, Shiao SL, Van Eyk JE, Zumsteg ZS, Journal of Clinical Oncology, 11/1/2017
  • Impact of Afirma gene expression classifier on cytopathology diagnosis and rate of thyroidectomy  
    Sacks WL, Bose S, Zumsteg ZS, Wong R, Shiao SL, Braunstein GD, Ho AS, Cancer, 10/1/2016
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Survival impact of treatment interval delays in head and neck cancer
    Ho AS, Kim S, Tighiouart M, Mita A, Scher K, Mallen-St. Clair J, Zumsteg ZS, ASTRO/ASCO/AHNS Multidisciplinary Head and Neck Cancer Symposium, Scottsdale, AZ, 2/1/2018
  • Proteomic stratification of HPV(+) oropharyngeal squamous cell carcinoma identifies targets in insulin receptor signaling within nonresponders
    Robinson A, Laury A, Parker SJ, Shiao SL, Knudsen B, Zumsteg ZS, Van Eyk JE, Ho AS, AACR-AHNS Head and Neck Cancer Conference, San Diego, CA, 1/1/2017
  • Management trends in active surveillance of papillary thyroid microcarcinoma
    Sacks WL, Melany ML, Chen IE, Braunstein GD, Ho AS, American Thyroid Association (ATA) Annual Meeting, Denver, CO, 9/1/2016
  • Join now to see all

Lectures

  • Low-risk thyroid cancers 
    American Thyroid Association Annual Meeting, Victoria BC, Canada - 10/1/2017
  • The calibrated thyroid surgeon: how ATA has modernized thyroid cancer management 
    Thyroid Cancer Grand Rounds, Cedars-Sinai Medical Center, Los Angeles, CA - 9/1/2017
  • Anaplastic thyroid carcinoma: managment principles for an unprincipled disease 
    Advances in the Management of Thyroid Cancer Symposium, Los Angeles, CA - 10/1/2016
  • Join now to see all

Press Mentions

  • Experts on medical legal trends associated with active surveillance
    Experts on medical legal trends associated with active surveillanceOctober 20th, 2023
  • Active Surveillance for Papillary Thyroid Cancer: When Is It The Right Choice?
    Active Surveillance for Papillary Thyroid Cancer: When Is It The Right Choice?March 14th, 2023
  • Safe to Expand Limits of Active Surveillance in Thyroid Cancer?
    Safe to Expand Limits of Active Surveillance in Thyroid Cancer?September 22nd, 2022
  • Join now to see all

Grant Support

  • Adenoid Cystic Carcinoma Research Foundation GrantACCRF2013–Present
  • Young Investigator Research Development AwardAHNS/AAO-HNSF2012–Present
  • T32 Ruth Kirschstein National Research Service AwardNIH2011–Present
  • Continuing Support ScholarshipHHMI2004–2006

Committees

  • Member, ATA Development Committee 2016 - Present

Professional Memberships

Other Languages

  • Chinese (Mandarin)

Hospital Affiliations